Drug-induced Sweet’s syndrome: pharmacovigilance insights from FAERS with a cross-database consistency assessment in VigiBase via LASSO and multivariable logistic regression
This study provides a comprehensive evaluation of drugs associated with DISS using real-world pharmacovigilance data. The results reveal both established and previously unrecognized drug triggers, offering important insights to support early detection, clinical management, and improved drug safety monitoring from statistical and clinical perspectives.
Authors
- Xiangqi Qin
- Ruimin Bai (ORCID: https://orcid.org/0000-0002-1691-7521)
- Yuhan Xie (ORCID: https://orcid.org/0009-0004-4842-9970)
- Qing Li (ORCID: https://orcid.org/0000-0002-4982-1024)
- Zhe Zhang (ORCID: https://orcid.org/0000-0002-3655-4342)
- Jing Zhou (ORCID: https://orcid.org/0000-0001-7838-4831)
Institutions
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.3389/fimmu.2025.1622736
- Citations
- 2
- Primary Topic
- Autoimmune and Inflammatory Disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.71
Funders
- World Health Organization
- National Natural Science Foundation of China